Delivery Order SPE2DB25D3003-SPE2DB25FPVWC
Award Date
2/28/25
Potential Completion Date
3/21/25
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has a period of performance through March 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the supply of NUBEQA 300 MG TABLET 120S, a prescription pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of March 19, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,641.98 firm fixed-price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,640.00, is for the delivery of 4,567,221,300 units of the medication NUBEQA 300 MG TABLET 120S. This is a firm fixed-price delivery order contract with a completion date of March 4, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $7,641.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of February 3, 2025. The contract is for the supply of the drug NUBEQA 300 MG TABLET 120S. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, to the U.S. government. The contract, valued at $7,641.98, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. There was no set-aside designation for this contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,567.92, is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has a completion date of February 11, 2025 and is a Firm Fixed Price Delivery Order. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $7,641.98, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, which is a Delivery Order, is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of February 18, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award is for the delivery of the pharmaceutical product NUBEQA 300 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The $7,036.80 firm fixed price delivery order was awarded to the pharmaceutical distributor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. Amerisourcebergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,683.97 Firm Fixed Price Delivery Order covers the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, to support military healthcare programs. The contract has a completion date of December 11, 2024 and was awarded on November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite...